help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Am. J. Respir. Crit. Care Med., Volume 164, Number 10, November 2001, 1760a-1760

REBUTTAL FROM DR. MACNEE


    ARTICLE
TOP
ARTICLE

Dr. Wedzicha concludes that the evidence is now compelling that "airway infection, especially with bacteria, is associated with . . . susceptibility to decline in lung function." However, only circumstantial or in some instances no evidence is provided to support this view.

It does not follow that the heterogeneity in the decline in FEV1 in smokers suggests a role for infection in the natural history of COPD; rather, it might suggest that genetic factors have a role as at least there are some supportive studies in this area.

The presence of bacterial colonization in a proportion of patients with COPD is not disputed, and there is increasing evidence that this is associated with increased airway inflammation. However, there is no longitudinal study that directly links bacterial colonization, or increased airway inflammation, to the decline in lung function.

The role of bacteria in exacerbations of COPD is still controversial and it does not follow, as suggested by Dr. Wedzicha, that the presence of higher levels of airspace inflammation, in limited studies, in bacterial exacerbations, leads to decline in lung function.

Further controversies are the effect of exacerbations on lung function decline and the evidence for lack of recovery in lung function, which is not universal in all studies. The associations of Haemophilus influenzae, increased airway inflammation, health status, and frequent exacerbations are not relevant to the argument for accelerated decline in lung function.

Furthermore, the association between latent adenoviral infection and COPD is irrelevant because it does not relate to the decline in lung function. In any case this hypothesis, although interesting, remains a hypothesis until it has been replicated in other studies, as does the contention that viral colonization has any relevance to COPD.

In short, there is no direct evidence of a role for infection in accelerating the decline in lung function in COPD. My only point of agreement with Dr. Wedzicha is that definitive studies have not been done and require to be done to prove or refute this hypothesis, but the evidence at present provides no support for this contention.






This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society